Presentation of donor major histocompatibility complex class II antigens by DNA vaccination prolongs heart allograft survival

Transplantation

Volumn 77, Issue 5, 2004, Pages 733-740

  Pêche, Hélène ^a   Van Denderen, Bryce ^b   Roussel, Jean Christian ^a   Trinité, Benjamin ^a   Soulillou, Jean Paul ^a   Cuturi, Maria Cristina ^a,c  

^a Inst Natl de la Recherche   (France)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PLASMID DNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMORAL IMMUNITY; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; VACCINATION;

ANIMALS; ANTIBODY FORMATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; MALE; PLASMIDS; RATS; RATS, INBRED LEW; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS; VACCINES, DNA;

EID: 1642327517     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000114613.70156.DB     Document Type: Article

References (30)

1. Soulillou JP, Blandin F, Gunther E, et al. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 1984; 38(1): 63.
2. Madsen JC, Superina RA, Wood KJ, et al. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332(6160): 161.
3. Sayegh MH, Perico N, Imberti O, et al. Thymic recognition of class 11 major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993; 56(2): 461.
4. Sonntag KC, Emery DW, Yasumoto, A, et al. Tolerance to solid organ transplants through transfer of MHC class II genes. J Clin Invest 2001; 107(1): 65.
5. Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Front Biosci 1999; 4: D476.
6. Benichou G, Takizawa PA, Olson CA, et al. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175(1): 305.
7. Auchincloss H Jr., Lee R, Shea S, et al. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A 1993; 90(8): 3373.
8. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177(6): 1643.
9. Vella JP, Spadafora-Ferreira M, Murphy B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64(6): 795.
10. Pardoll DM, Beckerleg AM. Exposing the immunology of naked DNA vaccines, Immunity 1995; 3(2): 165.
11. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259(5102): 1745.
12. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57(2): 225.
13. Joly E, Clarkson C, Howard JC, et al. Isolation of a functional cDNA encoding the RT1. Au MHC class I heavy chain by a novel PCR-based method. Immunogenetics 1995; 41(5): 326.
14. Syha-Jedelhauser J, Reske K. Sequence of rat cDNA clone pLR beta 112 coding for the RT1. D beta I chain. Nucleic Acids Res 1990; 18(15):4598.
15. Robertson KA, McMaster WR. Complete structure of a rat RT1 E beta chain: extensive conservation of MHC class II beta chains. J Immunol 1985; 135(6): 4095.
16. Holowachuk EW, Greer MK, Martin DR. The complete sequence of the MHC class II chain RT. 1D alpha u of the diabetic BB rat: mRNA levels of RT1. D alpha in lymphocytes. Nucleic Acids Res 1987; 15(24): 10551.
17. Wang M, Stepkowski SM, Tian L, et al. Nucleotide sequences of three distinct clones coding for the rat heavy chain class I major histocompatibility antigens. Immunogenetics 1996; 43: 318.
18. McWhinnie DL, Thompson JF, Taylor HM, et al. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 1986; 42(4): 352.
19. Pêche H, Michèle H, Usal C, et al. Presentation of donor MHC antigens by bone marrow dendritic cell derived exosomes modulates allograft rejection. Transplantation 2003; 76(10): 1503.
20. Voisine C, Hubert FX, Trinite B, et al. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J Immunol 2002; 169(5): 2284.
21. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993; 11(9): 957.
22. Saoudi A, Bernard I, Hoedemaekers A, et al. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. J Immunol 1999; 162(12): 7189.
23. Sayegh MH, Krensky AM. Novel immunotherapeutic strategies using MHC derived peptides. Kidney Int Suppl 1996; 53: S13.
24. Bohm W, Mertens T, Schirmbeck R, et al. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 1998; 16 (9-10): 949.
25. Hamelmann E, Wottge HU, Gassmann W, et al. Induction of tolerance after facilitation of engraftment with a monoclonal antibody anti-MHC class II in MHC fully allogeneic transplantation. Transplant Proe 1990; 22(5): 2340.
26. Priestley CA, Fabre JW. Different patterns of donor MHC antigen induction in rat kidney allografts following active and passive enhancement. Transplantation 1989; 48(2): 275.
27. Soulillou JP, Carpenter CB, d'Apice AJ, et al. The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med 1976; 143(2): 405.
28. Cuturi MC, Josien R, Cantarovich D, et al. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats. Eur J Immunol 1994; 24(7): 1627.
29. Gagne K, Brouard S, Guillet M, et al. TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down- regulation. Eur J Immunol 2001; 31(10): 3111.
30. MacPherson GG, Christmas SE. The role of the macrophage in cardiac allograft rejection in the rat. Immunol Rev 1984; 77: 143.